NMDA Receptor Antagonist Felbamate Reduces Behavioral Deficits and Blood–Brain Barrier Permeability Changes after Experimental Subarachnoid Hemorrhage in the Rat
Open accessThe DOI matches its Crossref record.
Abstract
Increased levels of glutamate and aspartate have been detected after subarachnoid hemorrhage (SAH) that correlate with neurological status. The NMDA receptor antagonist felbamate (FBM; 2-phenyl-1,3-propanediol dicarbamate) is an anti-epileptic drug that elicits neuroprotective effects in different experimental models of hypoxia-ischemia. The aim of this dose-response study was to evaluate the effect of FBM after experimental SAH in rats on (1) behavioral deficits (employing a battery of assessment tasks days 1-5 post-injury) and (2) blood-brain barrier (BBB) permeability changes (quantifying microvascular alterations according to the extravasation of protein-bound Evans Blue by a spectrophotofluorimetric technique 2 days post-injury). Animals were injected with 400 muL of autologous blood into the cisterna magna. Within 5 min, rats received daily oral administration of FBM (15, 30, or 45 mg/kg) for 2 or 5 days. Results were compared with sham-injured controls treated with oral saline or FBM (15, 30, or 45 mg/kg). FBM administration significantly ameliorated SAH-related changes in Beam Balance scores on days 1 and 2 and Beam Balance time on days 1-3, Beam Walking performance on days 1 and 2, and Body Weight on days 3-5. FBM also decreased BBB permeability changes in frontal, temporal, parietal, occipital, and cerebellar cortices; subcortical and cerebellar gray matter; and brainstem. This study demonstrates that, in terms of behavioral and microvascular effects, FBM is beneficial in a dose-dependent manner after experimental SAH in rats. These results reinforce the concept that NMDA excitotoxicity is involved in the cerebral dysfunction that follows SAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733
The importance of early brain injury after subarachnoid hemorrhage
Sehba, F. A., Hou, J., Pluta, R. M., & Zhang, J. H. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.003 · Cited by 571
Early Brain Injury, an Evolving Frontier in Subarachnoid Hemorrhage Research
Fujii, M., Yan, J., Rolland, W. B., Soejima, Y., Caner, B., & Zhang, J. H. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0257-2 · Cited by 493
Controversies and evolving new mechanisms in subarachnoid hemorrhage
Chen, S., Feng, H., Sherchan, P., Klebe, D., Zhao, G., Sun, X., Zhang, J., Tang, J., & Zhang, J. H. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.002 · Cited by 344
Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review
Lucke-Wold, B., Logsdon, A., Manoranjan, B., Turner, R., McConnell, E., Vates, G., Huber, J., Rosen, C., & Simard, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040497 · Cited by 306
Iron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
“Besides potentially being toxic to neurons, glutamate could promote injury directly to oligodendrocytes, e.g., via AMPA/kainate and/or NMDA receptors (Benarroch, 2009; Matute, 2011), or potentially promote leakage of the BBB (Germanò et al, 2007; Wu et al., 2013) (Figure 1).”
BackgroundInfluentialZheng, X., Li, W., Xiang, Q., Wang, Y., Qu, T., Fang, W., & Yang, H. (2023) · ACS Omega · doi:10.1021/acsomega.3c06250 · Cited by 10
Metadata
- Authors
- Germanò, A., Caffo, M., Angileri, F. F., Arcadi, F., Newcomb-Fernandez, J., Caruso, G., Meli, F., Pineda, J. A., Lewis, S. B., Wang, K. K. W., Bramanti, P., Costa, C., & Hayes, R. L.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2007-04
- Volume
- 24
- Issue
- 4
- Pages
- 732-744
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W1972627268
- Cited by
- 58
- References
- 0
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.